Corrigendum: Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 (Onco Targets Ther. 2019, 12, 869–882.)

J. Wang; H. Li; C. Xia

doi:10.2147/OTT.S392180

Corrigendum: Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 (Onco Targets Ther. 2019, 12, 869–882.)

J. Wang
, H. Li
, C. Xia

School of Chemistry and Chemical Engineering

Research output: Contribution to journal › Comment/debate

Abstract

The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.

Original language	English
Pages (from-to)	1143-1145
Number of pages	3
Journal	OncoTargets and Therapy
Volume	15
DOIs	https://doi.org/10.2147/OTT.S392180
Publication status	Published - 2022

Access to Document

10.2147/OTT.S392180

Cite this

@article{f1835e2197874463b7c43ef26066247c,

title = "Corrigendum: Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 (Onco Targets Ther. 2019, 12, 869–882.)",

abstract = "The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.",

author = "J. Wang and H. Li and C. Xia",

note = "Publisher Copyright: {\textcopyright} 2022 Wang et al.",

year = "2022",

doi = "10.2147/OTT.S392180",

language = "English",

volume = "15",

pages = "1143--1145",

journal = "OncoTargets and Therapy",

issn = "1178-6930",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - Corrigendum

T2 - Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 (Onco Targets Ther. 2019, 12, 869–882.)

AU - Wang, J.

AU - Li, H.

AU - Xia, C.

PY - 2022

Y1 - 2022

N2 - The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.

AB - The authors have advised Figure 2E on page 874 is incorrect. Due to an error at the time of figure assembly NC (24 h) and shCENPK (48 h) in the SMMC-7721 row were inadvertently duplicated. The correct Figure 2 is as follows.

UR - https://www.scopus.com/pages/publications/85139501126

U2 - 10.2147/OTT.S392180

DO - 10.2147/OTT.S392180

M3 - Comment/debate

AN - SCOPUS:85139501126

SN - 1178-6930

VL - 15

SP - 1143

EP - 1145

JO - OncoTargets and Therapy

JF - OncoTargets and Therapy

ER -

Corrigendum: Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 (Onco Targets Ther. 2019, 12, 869–882.)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this